RonaldDanielEmkeyMD

PubMed

• 78 citations
  Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial.
  Kenneth G. Saag, Nicola Pannacciulli, Piet Geusens, Jonathan D. Adachi, Osvaldo D. Messina, J. Morales-Torres, Ronald Emkey, Peter W. Butler, Xiang Yin, Willem F. Lems> ;Arthritis & Rheumatology. 2019 May 25
• 110 citations
  Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
  Kenneth G. Saag, Rachel B. Wagman, Piet Geusens, Jonathan D. Adachi, Osvaldo D. Messina, Ronald Emkey, Roland Chapurlat, Andrea Wang, Nicola Pannacciulli, Willem F. Lems> ;The Lancet. Diabetes & Endocrinology. 2018 Jun 1
• 21 citations
  Calcium metabolism and correcting calcium deficiencies.
  Ronald D. Emkey, Gregory R. Emkey> ;Endocrinology and Metabolism Clinics of North America. 2012 Sep 1
• 25 citations
  Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): Additional results from the monthly oral therapy with iba...
  Ronald Emkey, Pierre D. Delmas, Michael A. Bolognese, João Lindolfo C. Borges, Felicia Cosman, Sergio Ragi-Eis, Christopher Recknor, Cristiano A. F. Zerbini, Colin Nea...> ;Clinical Therapeutics. 2009 Apr 1
• Quarterly intravenous ibandronate for postmenopausal osteoporosis
  Ronald D Emkey> ;Women's Health. 2008 Apr 24
• 1 citations
  Ibandronate: once-monthly and intravenous dosing options for osteoporosis treatment
  Ronald D Emkey> ;Women's Health. 2006 Apr 25
• 63 citations
  Improving compliance and persistence with bisphosphonate therapy for osteoporosis
  Ronald Emkey, Mark P. Ettinger> ;The American Journal of Medicine. 2006 Apr 1
• 117 citations
  Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporo...
  Ronald Emkey, William Koltun, Kathleen Beusterien, Larry Seidman, Alan Kivitz, Vipul Devas, Daiva Masanauskaite> ;Current Medical Research and Opinion. 2005 Oct 24
• 17 citations
  Alendronate and risedronate for the treatment of postmenopausal osteoporosis: clinical profiles of the once-weekly and once-daily dosing formulations.
  Ronald Emkey> ;Medgenmed. 2004 Jul 19
• 80 citations
  Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory ...
  Ronald Emkey, Norman R. Rosenthal, Shu-Chen Wu, Donna Jordan, Marc Kamin> ;The Journal of Rheumatology. 2004 Jan 1
• 25 citations
  Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients - A retrospective, observational study
  Ronald Emkey, Pierre D. Delmas, Stefan Goemaere, Uri A. Liberman, Patrice E. Poubelle, Daifotis Anastasia G, N. Verbruggen, Antonio Lombardi, Michelle Czachur> ;Arthritis and Rheumatism. 2003 Apr 1
• Join now to see all